Latest News
Featured News
Select the category
Investor Update: 24 April 2025
Scancell’s new partnership with the NHS Vaccine Launch Pad (CLVP) March 2025
Partnership with NHS Cancer Vaccine Launch Pad Enabling Fast-Tracked Access for Melanoma Patients
Scancell to Present Clinical Data from the Ongoing Phase 2 SCOPE Trial of SCIB1 at 2025 AACR Annual Meeting
AACR 10 (American Association for Cancer Research), February 2025, Los Angeles, California
Issue of share options
Scancell to present translational data from the Phase 2 ongoing SCOPE trial of SCIB1 at the 2025 AACR IO conference
Scancell FY25 Interim Results Presentation
CEO Phil L’Huillier gives update on Scancell progress to Proactive
FY25 Interim Results: Products, People and Progress
H125 reaffirms funds are sufficient to deliver key data
Interim Results for the six months ended 31 October 2024
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.